Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Anemia

Free Subscription Articles published in Lancet Retrieve available abstracts of 19 articles: HTML format

Single Articles

December 2025
1. 
   Global, regional, and national progress towards the 2030 global nutrition targets and forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021.
   Lancet. 2025;404:2543-2583.
   PubMed     Abstract available
   
   
   
2. RIO P, Zubicaray J, Navarro S, Galvez E, et al
   Haematopoietic gene therapy of non-conditioned patients with Fanconi anaemia-A: results from open-label phase 1/2 (FANCOLEN-1) and long-term clinical trials.
   Lancet. 2025;404:2584-2592.
   PubMed     Abstract available
   
   
   July 2025
3. TAHER AT, Al-Samkari H, Aydinok Y, Besser M, et al
   Mitapivat in adults with non-transfusion-dependent alpha-thalassaemia or beta-thalassaemia (ENERGIZE): a phase 3, international, randomised, double-blind, placebo-controlled trial.
   Lancet. 2025;406:33-42.
   PubMed     Abstract available
   
   
   November 2024
4. KWIATKOWSKI JL, Walters MC, Hongeng S, Yannaki E, et al
   Betibeglogene autotemcel gene therapy in patients with transfusion-dependent, severe genotype beta-thalassaemia (HGB-212): a non-randomised, multicentre, single-arm, open-label, single-dose, phase 3 trial.
   Lancet. 2024;404:2175-2186.
   PubMed     Abstract available
   
   
   October 2024
5. 
   The effect of tranexamic acid on postpartum bleeding in women with moderate and severe anaemia (WOMAN-2): an international, randomised, double-blind, placebo-controlled trial.
   Lancet. 2024;404:1645-1656.
   PubMed     Abstract available
   
   
   July 2024
6. MEULENBELD A, Ramondt S, Sweegers MG, Quee FA, et al
   Effectiveness of ferritin-guided donation intervals in whole-blood donors in the Netherlands (FIND'EM): a stepped-wedge cluster-randomised trial.
   Lancet. 2024;404:31-43.
   PubMed     Abstract available
   
   
   May 2024
7. PASRICHA SR, Rogers L, Branca F, Garcia-Casal MN, et al
   Measuring haemoglobin concentration to define anaemia: WHO guidelines.
   Lancet. 2024;403:1963-1966.
   PubMed    
   
   
   April 2024
8. D'ANGELO SP, Araujo DM, Abdul Razak AR, Agulnik M, et al
   Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial.
   Lancet. 2024;403:1460-1471.
   PubMed     Abstract available
   
   
   January 2024
9. WEST EE, Woodruff T, Fremeaux-Bacchi V, Kemper C, et al
   Complement in human disease: approved and up-and-coming therapeutics.
   Lancet. 2024;403:392-405.
   PubMed     Abstract available
   
   
   December 2023
10. THE LANCET
    The promise of genetic therapies in sickle cell disease.
    Lancet. 2023;402:2265.
    PubMed    
    
    
    November 2023
11. BRADFORD DRR, Swift A, Allik M, McMahon AD, et al
    Physical health of care-experienced young children in high-income countries: a scoping review.
    Lancet. 2023;402 Suppl 1:S28.
    PubMed     Abstract available
    
    
    September 2023
12. ROBERTS I, Jones CP
    Structural racism and iron deficiency anaemia.
    Lancet. 2023;402:834-835.
    PubMed    
    
    
    July 2023
13. AGARWAL N, Azad AA, Carles J, Fay AP, et al
    Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial.
    Lancet. 2023;402:291-303.
    PubMed     Abstract available
    
    
    
14. DASHRAATH P, Lim KMX, Chin HL, Sidek A, et al
    Non-immune hydrops fetalis caused by Diamond-Blackfan anaemia and a mutation of the RPL15 gene.
    Lancet. 2023;402:141.
    PubMed    
    
    
    June 2023
15. PLATZBECKER U, Della Porta MG, Santini V, Zeidan AM, et al
    Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial.
    Lancet. 2023 Jun 9:S0140-6736(23)00874-7. doi: 10.1016/S0140-6736(23)00874.
    PubMed     Abstract available
    
    
    May 2023
16. CONRAD N, Misra S, Verbakel JY, Verbeke G, et al
    Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK.
    Lancet. 2023 May 5:S0140-6736(23)00457-9. doi: 10.1016/S0140-6736(23)00457.
    PubMed     Abstract available
    
    
    April 2023
17. SHAND AW, Kidson-Gerber GL
    Anaemia in pregnancy: a major global health problem.
    Lancet. 2023 Apr 20:S0140-6736(23)00396-3. doi: 10.1016/S0140-6736(23)00396.
    PubMed    
    
    
    
18. PASRICHA SR, Mwangi MN, Moya E, Ataide R, et al
    Ferric carboxymaltose versus standard-of-care oral iron to treat second-trimester anaemia in Malawian pregnant women: a randomised controlled trial.
    Lancet. 2023 Apr 20:S0140-6736(23)00278-7. doi: 10.1016/S0140-6736(23)00278.
    PubMed     Abstract available
    
    
    
19. PEPE J, Cipriani C, Colangelo L, Minisola S, et al
    Avascular necrosis in both hips in a patient with transfusion dependent beta-thalassaemia.
    Lancet. 2023;401:e19.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Anemia is free of charge.